Gráfico del Precio de Acciones BLRX
BLRX Ganando
BioLineRx Ltd.
$3.1
-7.46%
$-0.25
Al cierre: May 07, 16:00:00 GMT-4
$3.1
0%
$0
Mercado Posterior: May 07, 20:00:00 GMT-4
Atrás
BioLineRx Ltd. (BLRX) Ganando
Estadísticas clave
Cierre Anterior
$3.35
Precio de apertura
$3.29
Rango del día
$3.1 - $3.33
Rango de 52 semanas
$2.15 - $7.77
Volumen
13.5K
Volumen promedio
18.3K
Rendimiento de dividendos
--
EPS (TTM)
0.00
Cap. de mercado
$13.4M
¿Qué es BioLineRx Ltd.?
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
Características
© 2026 Edgen impulsado por